GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » Cyclically Adjusted Revenue per Share

Neurologix (Neurologix) Cyclically Adjusted Revenue per Share : $0.00 (As of Jun. 2011)


View and export this data going back to . Start your Free Trial

What is Neurologix Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Neurologix's adjusted revenue per share for the three months ended in Jun. 2011 was $0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Jun. 2011.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-05-23), Neurologix's current stock price is $1.0E-6. Neurologix's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2011 was $0.00. Neurologix's Cyclically Adjusted PS Ratio of today is .


Neurologix Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Neurologix's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix Cyclically Adjusted Revenue per Share Chart

Neurologix Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neurologix Quarterly Data
Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Neurologix's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Neurologix's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurologix's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurologix's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Neurologix's Cyclically Adjusted PS Ratio falls into.



Neurologix Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Neurologix's adjusted Revenue per Share data for the three months ended in Jun. 2011 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2011 (Change)*Current CPI (Jun. 2011)
=0/95.2345*95.2345
=0.000

Current CPI (Jun. 2011) = 95.2345.

Neurologix Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200109 0.242 75.227 0.306
200112 -0.076 74.552 -0.097
200203 0.103 75.438 0.130
200206 0.000 75.902 0.000
200209 0.000 76.366 0.000
200212 0.000 76.324 0.000
200303 0.097 77.716 0.119
200306 0.000 77.505 0.000
200309 0.000 78.138 0.000
200312 0.000 77.758 0.000
200403 0.000 79.066 0.000
200406 0.000 80.037 0.000
200409 0.000 80.121 0.000
200412 0.000 80.290 0.000
200503 0.000 81.555 0.000
200506 0.000 82.062 0.000
200509 0.000 83.876 0.000
200512 0.000 83.032 0.000
200603 0.000 84.298 0.000
200606 0.000 85.606 0.000
200609 0.000 85.606 0.000
200612 0.000 85.142 0.000
200703 0.000 86.640 0.000
200706 0.000 87.906 0.000
200709 0.000 87.964 0.000
200712 0.000 88.616 0.000
200803 0.000 90.090 0.000
200806 0.000 92.320 0.000
200809 0.000 92.307 0.000
200812 0.000 88.697 0.000
200903 0.000 89.744 0.000
200906 0.000 91.003 0.000
200909 0.000 91.120 0.000
200912 0.000 91.111 0.000
201003 0.000 91.821 0.000
201006 0.000 91.962 0.000
201009 0.000 92.162 0.000
201012 0.000 92.474 0.000
201103 0.000 94.283 0.000
201106 0.000 95.235 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Neurologix  (GREY:NRGXQ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Neurologix Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Neurologix's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurologix (Neurologix) Business Description

Industry
Traded in Other Exchanges
N/A
Address
One Bridge Plaza, Fort Lee, NJ, USA, 07024
Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines